5/20/22 16:47 | 8/18/21 | PHAS | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | PA | D | | P.a | 9 | 3.08 | 0 | 3 | 9 | 38 | I | | | | | | | | | | | | | | |
8/19/21 16:24 | 8/18/21 | PHAS | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | PA | D | | P | 9 | 3.08 | 0 | 3 | 300 | 4 | I | | | | | | | | | | | | | | |
8/18/21 18:07 | 8/18/21 | PHAS | Health | Drug | Pharmaceutical Preparations | Thorp Clay | PA | D | | P | 30 | 3.00 | 0 | 10 | 44 | 33 | D | | | | | | | | | | | | | | |
12/4/20 15:53 | 12/3/20 | PHAS | Health | Drug | Pharmaceutical Preparations | Harrigan Edmund | PA | D | | P | 25 | 4.12 | 0 | 6 | New | 6 | D | | | | | | | | | | | | | | |
11/24/20 16:04 | 11/23/20 | PHAS | Health | Drug | Pharmaceutical Preparations | Thorp Clay | PA | D | | P.m | 18 | 3.60 | 0 | 5 | 28 | 23 | D | | | | | | | | | | | | | | |
12/17/18 16:24 | 12/13/18 | PHAS | Health | Drug | Pharmaceutical Preparations | Ballance David James | PA | O | VP,Resea | P | 4 | 3.94 | 0 | 1 | 15 | 8 | D | | | | | | | | | | | | | | |
12/17/18 16:19 | 12/17/18 | PHAS | Health | Drug | Pharmaceutical Preparations | Hutson Nancy J | PA | D | | P | 4 | 4.46 | 0 | 1 | New | 1 | I | | | | | | | | | | | | | | |
12/17/18 16:18 | 12/13/18 | PHAS | Health | Drug | Pharmaceutical Preparations | Mow Jonathan P | PA | DO | CEO | P | 4 | 3.69 | 0 | 1 | 2 | 51 | I | | | | | | | | | | | | | | |
12/13/18 17:04 | 12/7/18 | PHAS | Health | Drug | Pharmaceutical Preparations | Mow Jonathan P | PA | DO | CEO | P.am | 6 | 3.87 | 0 | 2 | 3 | 50 | I | | | | | | | | | | | | | | |
12/11/18 16:18 | 12/11/18 | PHAS | Health | Drug | Pharmaceutical Preparations | York Michael | PA | O | VP,Corpo | P | 6 | 3.88 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
12/11/18 16:16 | 12/7/18 | PHAS | Health | Drug | Pharmaceutical Preparations | Sharp John P | PA | O | CFO,Secr | P | 19 | 3.84 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
12/11/18 16:12 | 12/7/18 | PHAS | Health | Drug | Pharmaceutical Preparations | Mow Jonathan P | PA | DO | CEO | P.m | 12 | 3.87 | 0 | 3 | 6 | 52 | I | | | | | | | | | | | | | | |
12/6/18 09:15 | 12/4/18 | PHAS | Health | Drug | Pharmaceutical Preparations | Thorp Clay | PA | DT | | P | 13 | 3.13 | 0 | 4 | 0 | 2,474 | D | | | | | | | | | | | | | | |
10/24/18 17:01 | 10/22/18 | PHAS | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 13 LP | MD | T | | P.d | 9,000 | 5.00 | 0 | 1,800 | 37 | 6,642 | I | | | | | | | | | | | | | | |
10/24/18 16:20 | 10/22/18 | PHAS | Health | Drug | Pharmaceutical Preparations | Tufts Linda | PA | D | | P.d | 100 | 5.00 | 0 | 20 | 2 | 931 | I | | | | | | | | | | | | | | |
10/24/18 16:19 | 10/22/18 | PHAS | Health | Drug | Pharmaceutical Preparations | Thorp Clay | PA | DT | | P.d | 1,500 | 5.00 | 0 | 300 | 14 | 2,470 | I | | | | | | | | | | | | | | |
10/24/18 16:18 | 10/22/18 | PHAS | Health | Drug | Pharmaceutical Preparations | Hatteras Venture Advisors Iii, LLC | NC | T | | P.d | 1,500 | 5.00 | 0 | 300 | 14 | 2,458 | I | | | | | | | | | | | | | | |
10/24/18 16:16 | 10/22/18 | PHAS | Health | Drug | Pharmaceutical Preparations | Astrazeneca Plc | X0 | T | | P.d | 3,000 | 5.00 | 0 | 600 | 25 | 3,005 | I | | | | | | | | | | | | | | |